Association of angiotensin modulators with the course of idiopathic pulmonary fibrosis
Background - Angiotensin peptides have been implicated in idiopathic pulmonary fibrosis (IPF) pathogenesis. Angiotensin modulators are used to treat arterial hypertension, a frequent comorbidity of IPF. This post hoc analysis evaluated associations of antihypertensive treatments with disease-related...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
29 April 2019
|
| In: |
Chest
Year: 2019, Jahrgang: 156, Heft: 4, Pages: 706-714 |
| ISSN: | 1931-3543 |
| DOI: | 10.1016/j.chest.2019.04.015 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1016/j.chest.2019.04.015 Verlag: http://www.sciencedirect.com/science/article/pii/S0012369219308827 
|
| Verfasserangaben: | Michael Kreuter, David J. Lederer, Maria Molina-Molina, Imre Noth, Claudia Valenzuela, Lutz Frankenstein, Derek Weycker, Mark Atwood, Klaus-Uwe Kirchgaessler, and Vincent Cottin |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1689724935 | ||
| 003 | DE-627 | ||
| 005 | 20240404193231.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200210s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.chest.2019.04.015 |2 doi | |
| 035 | |a (DE-627)1689724935 | ||
| 035 | |a (DE-599)KXP1689724935 | ||
| 035 | |a (OCoLC)1341304359 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kreuter, Michael |d 1972- |e VerfasserIn |0 (DE-588)122645995 |0 (DE-627)082066795 |0 (DE-576)293362742 |4 aut | |
| 245 | 1 | 0 | |a Association of angiotensin modulators with the course of idiopathic pulmonary fibrosis |c Michael Kreuter, David J. Lederer, Maria Molina-Molina, Imre Noth, Claudia Valenzuela, Lutz Frankenstein, Derek Weycker, Mark Atwood, Klaus-Uwe Kirchgaessler, and Vincent Cottin |
| 264 | 1 | |c 29 April 2019 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 10.02.2020 | ||
| 520 | |a Background - Angiotensin peptides have been implicated in idiopathic pulmonary fibrosis (IPF) pathogenesis. Angiotensin modulators are used to treat arterial hypertension, a frequent comorbidity of IPF. This post hoc analysis evaluated associations of antihypertensive treatments with disease-related outcomes in IPF. - Methods - All patients randomized to placebo (n = 624) in the CAPACITY and ASCEND studies were categorized by antihypertensive treatment at baseline. Outcomes of disease progression (first occurrence of ≥ 10% absolute decline in % predicted FVC, ≥ 50-m decline in 6-min walk distance, or death) and all-cause mortality were assessed over 52 weeks. - Results - At baseline, 111 and 121 patients were receiving an angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin II receptor blocker (ARB), respectively; 392 were receiving neither. In multivariable analyses adjusted for differences in baseline characteristics compared with the non-ACEi/ARB group, ACEi treatment (hazard ratio [HR], 0.6 [95% CI, 0.4-0.9]; P = .026), but not ARB (HR, 0.9 [95% CI, 0.6-1.2]; P = .413), was associated with slower disease progression. Furthermore, the increase in all-cause mortality associated with cardiovascular disease was not observed in the ACEi group (HR, 1.1 [95% CI, 0.5-2.9]; P = .782), which presented a similar percentage of IPF-related mortality as the non-ACEi/ARB group (3.6% vs 3.6%). In contrast, patients in the ARB group had greater risk of all-cause mortality (HR, 2.5 [95% CI, 1.2-5.2]). These observations were validated in a pooled analysis that included patients from the INSPIRE trial. - Conclusions - Prospective clinical trials are needed to evaluate whether angiotensin modulators may be beneficial to clinical outcomes in IPF. - Trial Registry - ClinicalTrials.gov; Nos.: NCT01366209, NCT00287716, NCT00287729, NCT00075998; URL: www.clinicaltrials.gov). | ||
| 650 | 4 | |a disease progression | |
| 650 | 4 | |a idiopathic pulmonary fibrosis | |
| 650 | 4 | |a interstitial lung disease | |
| 700 | 1 | |a Lederer, David |e VerfasserIn |0 (DE-588)1192313542 |0 (DE-627)1670624307 |4 aut | |
| 700 | 1 | |a Molina-Molina, Maria |e VerfasserIn |0 (DE-588)1274131197 |0 (DE-627)1823877753 |4 aut | |
| 700 | 1 | |a Noth, Imre |e VerfasserIn |4 aut | |
| 700 | 1 | |a Valenzuela, Claudia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Frankenstein, Lutz |d 1973- |e VerfasserIn |0 (DE-588)124198937 |0 (DE-627)63440766X |0 (DE-576)328373281 |4 aut | |
| 700 | 1 | |a Weycker, Derek |e VerfasserIn |4 aut | |
| 700 | 1 | |a Atwood, Mark |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kirchgaessler, Klaus-Uwe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cottin, Vincent |e VerfasserIn |0 (DE-588)1160685010 |0 (DE-627)1024082911 |0 (DE-576)506122018 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chest |d Amsterdam : Elsevier, 1935 |g 156(2019), 4, Seite 706-714 |h Online-Ressource |w (DE-627)320460819 |w (DE-600)2007244-2 |w (DE-576)09089202X |x 1931-3543 |7 nnas |a Association of angiotensin modulators with the course of idiopathic pulmonary fibrosis |
| 773 | 1 | 8 | |g volume:156 |g year:2019 |g number:4 |g pages:706-714 |g extent:9 |a Association of angiotensin modulators with the course of idiopathic pulmonary fibrosis |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.chest.2019.04.015 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0012369219308827 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20200210 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 124198937 |a Frankenstein, Lutz |m 124198937:Frankenstein, Lutz |d 910000 |d 910100 |e 910000PF124198937 |e 910100PF124198937 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 122645995 |a Kreuter, Michael |m 122645995:Kreuter, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PK122645995 |e 950000PK122645995 |e 950900PK122645995 |e 50000PK122645995 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1689724935 |e 3591803375 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"corporate":[{"display":"American College of Chest Physicians","roleDisplay":"Herausgebendes Organ","role":"isb"}],"id":{"eki":["320460819"],"zdb":["2007244-2"],"issn":["1931-3543"]},"titleAlt":[{"title":"Diseases of the chest"},{"title":"for pulmonologists, cardiologists, cardiothoracic surgeons, critical care physicians, and related specialists"},{"title":"the cardiopulmonary and critical care journal"},{"title":"for pulmonologists, cardiologists, cardiothoracic surgeons, critical care physicians, and related specialists"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1935 -"],"note":["Gesehen am 09.11.2017"],"recId":"320460819","part":{"issue":"4","volume":"156","extent":"9","year":"2019","pages":"706-714","text":"156(2019), 4, Seite 706-714"},"disp":"Association of angiotensin modulators with the course of idiopathic pulmonary fibrosisChest","language":["eng"],"origin":[{"dateIssuedDisp":"1935-","publisher":"Elsevier ; American College of Chest Physicians","publisherPlace":"Amsterdam ; Northbrook, Ill. [u.a.]","dateIssuedKey":"1935"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"official publication of the American College of Chest Physicians ; for specialists in pulmonology, critical care, sleep medicine, thoracic surgery, cardiorespiratory interactions and related disciplines","title_sort":"Chest","title":"Chest"}]}],"name":{"displayForm":["Michael Kreuter, David J. Lederer, Maria Molina-Molina, Imre Noth, Claudia Valenzuela, Lutz Frankenstein, Derek Weycker, Mark Atwood, Klaus-Uwe Kirchgaessler, and Vincent Cottin"]},"id":{"doi":["10.1016/j.chest.2019.04.015"],"eki":["1689724935"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"29 April 2019"}],"physDesc":[{"extent":"9 S."}],"language":["eng"],"person":[{"family":"Kreuter","display":"Kreuter, Michael","role":"aut","roleDisplay":"VerfasserIn","given":"Michael"},{"family":"Lederer","display":"Lederer, David","roleDisplay":"VerfasserIn","role":"aut","given":"David"},{"family":"Molina-Molina","role":"aut","roleDisplay":"VerfasserIn","given":"Maria","display":"Molina-Molina, Maria"},{"display":"Noth, Imre","role":"aut","roleDisplay":"VerfasserIn","given":"Imre","family":"Noth"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Claudia","display":"Valenzuela, Claudia","family":"Valenzuela"},{"display":"Frankenstein, Lutz","given":"Lutz","role":"aut","roleDisplay":"VerfasserIn","family":"Frankenstein"},{"display":"Weycker, Derek","roleDisplay":"VerfasserIn","role":"aut","given":"Derek","family":"Weycker"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Mark","display":"Atwood, Mark","family":"Atwood"},{"family":"Kirchgaessler","display":"Kirchgaessler, Klaus-Uwe","roleDisplay":"VerfasserIn","role":"aut","given":"Klaus-Uwe"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Vincent","display":"Cottin, Vincent","family":"Cottin"}],"title":[{"title_sort":"Association of angiotensin modulators with the course of idiopathic pulmonary fibrosis","title":"Association of angiotensin modulators with the course of idiopathic pulmonary fibrosis"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1689724935","note":["Gesehen am 10.02.2020"]} | ||
| SRT | |a KREUTERMICASSOCIATIO2920 | ||